Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.
Nanoscope Therapeutics has raised $1.5M in total funding. The most recent round was Grant. The last funding was announced in September 2021.
Nanoscope Therapeutics's investors include National Institutes of Health.
Nanoscope Therapeutics is headquartered in Bedford, United States.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.
Nanoscope Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanoscope Therapeutics — Funding & Investors." VCBacked, September 14, 2021, https://www.vcbacked.co/company/nanoscope-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Nanoscope Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nanoscope-therapeutics
{{cite web |title=Nanoscope Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nanoscope-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated